Optimizing diabetes management through glucose profiling: A case-based approach

Wild, 2004, Global prevalence of diabetes: estimates for the year 2000 and projections for 2030, Diabetes Care, 27, 1047, 10.2337/diacare.27.5.1047 Centers for Disease Control and Prevention, National diabetes fact sheet. United States, 2005, available from http://www.diabetes.org/diabetes-statistics.jsp (accessed October 6, 2005). Klein, 1996, Relation of glycemic control to diabetic microvascular complications in diabetes mellitus, Ann. Intern. Med., 124, 90, 10.7326/0003-4819-124-1_Part_2-199601011-00003 Stratton, 2000, Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study, BMJ, 321, 405, 10.1136/bmj.321.7258.405 2002, Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus, JAMA, 287, 2563, 10.1001/jama.287.19.2563 1993, The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus, N. Engl. J. Med., 329, 977, 10.1056/NEJM199309303291401 Skyler, 2002, Evidence for glycated hemoglobin targets from the diabetes control and complications trial, Endocr. Pract., 8, 27, 10.4158/EP.8.S1.27 American Diabetes Association, 2006, Standards of medical care in diabetes–2006, Diabetes Care, 29, S4, 10.2337/diacare.29.s1.06.s4 L’Agence Nationale d’Accréditation et d’Evaluation en Santé, 1999, Follow-up of the type 2 diabetic patient excluding follow-up of complications. Recommendations of ANAES, Diabetes Metab., 25, 1 European Diabetes Policy Group 1999, 1999, A desktop guide to Type 2 diabetes mellitus, Diabet. Med., 16, 716, 10.1046/j.1464-5491.1999.00166.x American Association of Clinical Endocrinologists, American College of Endocrinology, 2002, Medical guidelines for the management of diabetes mellitus: the AACE system of intensive diabetes self-management–2002 update, Endocr. Pract., 8, 40 2003, Targets for glycemic control, Can. J. Diab., 27, S18 1995, The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the Diabetes Control and Complications Trial, Diabetes, 44, 968, 10.2337/diabetes.44.8.968 Hempe, 2002, High and low hemoglobin glycation phenotypes in type 1 diabetes: a challenge for interpretation of glycemic control, J. Diabetes Complications, 16, 313, 10.1016/S1056-8727(01)00227-6 Rohlfing, 2002, Defining the relationship between plasma glucose and HbA1c: analysis of glucose profiles and HbA1c in the Diabetes Control and Complications Trial, Diabetes Care, 25, 275, 10.2337/diacare.25.2.275 Hillman, 2004, What is the relative contribution of blood glucose levels at different time points of the day to HbA1c in Type 1 diabetes?, Diabet. Med., 21, 468, 10.1111/j.1464-5491.2004.01184.x Nichols, 2005, What is accuracy and how close must the agreement be?, Diabetes Technol. Ther., 7, 558, 10.1089/dia.2005.7.558 UK Prospective Diabetes Study (UKPDS) Group, 1998, Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33), Lancet, 352, 837, 10.1016/S0140-6736(98)07019-6 Donnelly, 2005, Frequency and predictors of hypoglycaemia in Type 1 and insulin-treated Type 2 diabetes: a population-based study, Diabet. Med., 22, 749, 10.1111/j.1464-5491.2005.01501.x Bouma, 1999, How valid is fasting plasma glucose as a parameter of glycemic control in non-insulin-using patients with type 2 diabetes?, Diabetes Care, 22, 904, 10.2337/diacare.22.6.904 Monnier, 2002, Morning hyperglycemic excursions: a constant failure in the metabolic control of non-insulin-using patients with type 2 diabetes, Diabetes Care, 25, 737, 10.2337/diacare.25.4.737 Avignon, 1997, Nonfasting plasma glucose is a better marker of diabetic control than fasting plasma glucose in type 2 diabetes, Diabetes Care, 20, 1822, 10.2337/diacare.20.12.1822 Monnier, 2003, Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients: variations with increasing levels of HbA1c, Diabetes Care, 26, 881, 10.2337/diacare.26.3.881 Colette, 2005, Dichotomous responses of inter and postprandial hyperglycaemia to short-term calorie restriction in patients with type 2 diabetes, Eur. J. Clin. Invest., 35, 259, 10.1111/j.1365-2362.2005.01482.x Rodriguez, 1999, Glucose intolerance and 23-year risk of coronary heart disease and total mortality: the Honolulu Heart Program, Diabetes Care, 22, 1262, 10.2337/diacare.22.8.1262 Tominaga, 1999, Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose: the Funagata Diabetes Study, Diabetes Care, 22, 920, 10.2337/diacare.22.6.920 Qiao, 2002, Two-hour glucose is a better risk predictor for incident coronary heart disease and cardiovascular mortality than fasting glucose, Eur. Heart J., 23, 1267, 10.1053/euhj.2001.3113 de Vegt, 1999, Hyperglycaemia is associated with all-cause and cardiovascular mortality in the Hoorn population: the Hoorn Study, Diabetologia, 42, 926, 10.1007/s001250051249 Hanefeld, 1996, Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study, 11-year follow-up, Diabetologia, 39, 1577, 10.1007/s001250050617 Sievers, 1999, Effect of glycemia on mortality in Pima Indians with type 2 diabetes, Diabetes, 48, 896, 10.2337/diabetes.48.4.896 Barrett-Connor, 1998, Isolated postchallenge hyperglycemia and the risk of fatal cardiovascular disease in older women and men: the Rancho Bernardo Study, Diabetes Care, 21, 1236, 10.2337/diacare.21.8.1236 Pearson, 2001, Fine-tuning control: pattern management versus supplementation. View 1. Pattern management: an essential component of effective insulin management, Diabetes Spectrum, 14, 75, 10.2337/diaspect.14.2.75 Ohkubo, 1995, Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study, Diabetes Res. Clin. Pract., 28, 103, 10.1016/0168-8227(95)01064-K Welschen, 2005, Self-monitoring of blood glucose in patients with type 2 diabetes who are not using insulin: a systematic review, Diabetes Care, 28, 1510, 10.2337/diacare.28.6.1510 Langer, 1994, Intensified versus conventional management of gestational diabetes, Am. J. Obstet. Gynecol., 170, 1036, 10.1016/S0002-9378(94)70097-4 Jovanovic, 1998, American Diabetes Association's Fourth International Workshop-Conference on Gestational Diabetes Mellitus: summary and discussion. Therapeutic interventions, Diabetes Care, 21, B131 American College of Obstetricians and Gynecologists, ACOG Practice Bulletin, Clinical management guidelines for obstetrician–gynecologists, Number 30, September 2001 (replaces Technical Bulletin Number 200, December 1994), Gestational diabetes, Obstet. Gynecol. 98 (3) (2001) 525–538. American Diabetes Association, 2004, Gestational diabetes mellitus, Diabetes Care, 27, S88 McElduff, 2005, The Australasian Diabetes in Pregnancy Society consensus guidelines for the management of type 1 and type 2 diabetes in relation to pregnancy, Med. J. Aust., 183, 373, 10.5694/j.1326-5377.2005.tb07087.x